259 related articles for article (PubMed ID: 16183529)
21. Therapeutic alternatives in metastatic neuroendocrine tumors.
Miller CA; Ellison EC
Surg Oncol Clin N Am; 1998 Oct; 7(4):863-79. PubMed ID: 9735138
[TBL] [Abstract][Full Text] [Related]
22. Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours.
Marrache F; Vullierme MP; Roy C; El Assoued Y; Couvelard A; O'Toole D; Mitry E; Hentic O; Hammel P; Lévy P; Ravaud P; Rougier P; Ruszniewski P
Br J Cancer; 2007 Jan; 96(1):49-55. PubMed ID: 17164755
[TBL] [Abstract][Full Text] [Related]
23. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
[TBL] [Abstract][Full Text] [Related]
24. Ablative and catheter-delivered therapies for colorectal liver metastases (CRLM).
Evans J
Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S64-75. PubMed ID: 18061390
[TBL] [Abstract][Full Text] [Related]
25. Liver-directed treatment modalities for primary and secondary hepatic tumors.
Yamane B; Weber S
Surg Clin North Am; 2009 Feb; 89(1):97-113, ix. PubMed ID: 19186233
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis and treatment of colorectal liver metastases - workflow].
Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
[TBL] [Abstract][Full Text] [Related]
27. Endocrine tumours of the gastrointestinal tract: Chemotherapy.
Arnold R; Rinke A; Schmidt Ch; Hofbauer L
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):649-56. PubMed ID: 16183533
[TBL] [Abstract][Full Text] [Related]
28. Transhepatic artery chemoembolization for liver metastases of primary retroperitoneal endodermal sinus tumor. A case report.
Chen CL; Wang PH; Ng HT; Yuan CC
J Reprod Med; 1999 Jun; 44(6):559-62. PubMed ID: 10394553
[TBL] [Abstract][Full Text] [Related]
29. Endocrine tumours of the gastrointestinal tract. Management of metastatic endocrine tumours.
Plöckinger U; Wiedenmann B
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):553-76. PubMed ID: 16183527
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.
Toumpanakis C; Meyer T; Caplin ME
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):131-44. PubMed ID: 17382269
[TBL] [Abstract][Full Text] [Related]
31. Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy.
Christante D; Pommier S; Givi B; Pommier R
Surgery; 2008 Dec; 144(6):885-93; discussion 893-4. PubMed ID: 19040993
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and treatment of metastatic disease to the liver.
Arciero CA; Sigurdson ER
Semin Oncol; 2008 Apr; 35(2):147-59. PubMed ID: 18396200
[TBL] [Abstract][Full Text] [Related]
33. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options.
Arnold R
Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):491-505. PubMed ID: 16183523
[TBL] [Abstract][Full Text] [Related]
34. [Asymptomatic multinodular liver disease].
Cadiot G
Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B154-8. PubMed ID: 12843952
[No Abstract] [Full Text] [Related]
35. Re: Optimal strategies for combining transcatheter arterial chemoembolization and radiofrequency ablation in rabbit VX2 hepatic tumors.
Wright KC
J Vasc Interv Radiol; 2009 Jun; 20(6):851-2; author reply 852-3. PubMed ID: 19465311
[No Abstract] [Full Text] [Related]
36. Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques.
Hong K; Georgiades CS; Geschwind JF
Nat Clin Pract Oncol; 2006 Jun; 3(6):315-24. PubMed ID: 16757969
[TBL] [Abstract][Full Text] [Related]
37. [Hepatic chemoembolization for the treatment of carcinoid syndrome].
Kisilevzky N; dos Anjos LC; Carnevale F; de Souza CM; Mott Cde B; Laudana A; Magalhães AC
Rev Hosp Clin Fac Med Sao Paulo; 1995; 50(4):236-9. PubMed ID: 8560156
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes.
Henn AR; Levine EA; McNulty W; Zagoria RJ
AJR Am J Roentgenol; 2003 Oct; 181(4):1005-10. PubMed ID: 14500219
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic, surgical and medical aspect of the midgut carcinoids.
de Vries H; Verschueren RC; Willemse PH; Kema IP; de Vries EG
Cancer Treat Rev; 2002 Feb; 28(1):11-25. PubMed ID: 12027412
[TBL] [Abstract][Full Text] [Related]
40. Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors.
Kobayashi K; Gupta S; Trent JC; Vauthey JN; Krishnamurthy S; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; McRae SE; Hicks ME
Cancer; 2006 Dec; 107(12):2833-41. PubMed ID: 17096432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
